Status:
COMPLETED
Follow up to the AVANT Study up to 8 and 10 Years (Median Follow up) in Patients With Colon Carcinoma
Lead Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group
Collaborating Sponsors:
Hoffmann-La Roche
Conditions:
Colon Cancer Treated With Bevacizumab After Colon Surgery
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the S-AVANT study is to collect additional data at 8 and 10 years median follow up of patients previously included in the AVANT trial from December 2004 to June 2007. Clinical data of the ...
Eligibility Criteria
Inclusion
- All patients randomized in the AVANT trial.
Exclusion
- Written opposition from alive patients
Key Trial Info
Start Date :
March 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 15 2019
Estimated Enrollment :
1636 Patients enrolled
Trial Details
Trial ID
NCT02228668
Start Date
March 1 2015
End Date
February 15 2019
Last Update
February 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GERCOR
Paris, France